Farringdon Capital’s Alkermes ALKS Stock Holding History

Farringdon Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,084	Closed	-$204K	–	338
2024 Q4	$204K	Buy	+7,084	New	+$204K	0.08%	382

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Farringdon Capital's ALKS Position: Q1 2025 in Review

Farringdon Capital sold out of Alkermes (ALKS) in Q1 2025, closing a stake of 7,084 shares — an estimated $204K sold.

Farringdon Capital first reported a position in ALKS in Q4 2024 and held it in 1 quarter. The position peaked at $204K in Q4 2024. 371 funds tracked by Wall St. Rank hold ALKS as of Q1 2025.

Farringdon Capital reported no remaining Alkermes position as of Q1 2025 after selling out during the quarter.
Farringdon Capital sold 7,084 Alkermes shares in Q1 2025, an estimated $204K.
Farringdon Capital first reported a position in Alkermes in Q4 2024 and held it in 1 quarter.
Farringdon Capital's Alkermes position peaked at $204K in Q4 2024.
371 funds tracked by Wall St. Rank held Alkermes as of Q1 2025.

Based on Farringdon Capital's 13F filing for Q1 2025, filed 15 May 2025.